Have a feature idea you'd love to see implemented?
Let us know!
LQDA Liquidia Corp
Price (delayed)
$10.15
Market cap
$859.06M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.63
Enterprise value
$770.53M
Liquidia Corporation is a biopharmaceutical company focused on the development and commercialization of products in pulmonary hypertension and other applications of its PRINT technology. The Company operates through two subsidiaries,
Highlights
LQDA's equity has surged by 130% year-on-year and by 76% since the previous quarter
LQDA's revenue is down by 15% YoY but it is up by 5% QoQ
The quick ratio is up by 9% QoQ but it is down by 6% YoY
The company's debt has surged by 139% YoY and by 30% QoQ
LQDA's net income has plunged by 107% YoY and by 7% from the previous quarter
Key stats
What are the main financial stats of LQDA
Market
Valuations
Earnings
Shares outstanding
84.64M
Market cap
$859.06M
Enterprise value
$770.53M
Price to earnings (P/E)
N/A
Price to book (P/B)
7.05
Price to sales (P/S)
50.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.36
Revenue
$15.61M
EBIT
-$109.39M
EBITDA
-$106.74M
Free cash flow
-$92.46M
Per share
Balance sheet
Liquidity
EPS
-$1.63
Free cash flow per share
-$1.18
Book value per share
$1.44
Revenue per share
$0.2
TBVPS
$3.14
Total assets
$252.89M
Total liabilities
$142.37M
Debt
$115.84M
Equity
$110.52M
Working capital
$180.37M
Debt to equity
1.05
Current ratio
6.33
Quick ratio
6.16
Net debt/EBITDA
0.83
Margins
Efficiency
Dividend
EBITDA margin
-683.8%
Gross margin
64.7%
Net margin
-765.4%
Operating margin
-715.1%
Return on assets
-64.1%
Return on equity
-155.8%
Return on invested capital
-114.8%
Return on capital employed
-49.9%
Return on sales
-700.8%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
LQDA stock price
How has the Liquidia stock price performed over time
Intraday
0.3%
1 week
1.25%
1 month
-8.48%
1 year
53.79%
YTD
-15.63%
QTD
1.5%
Financial performance
How have Liquidia's revenue and profit performed over time
Revenue
$15.61M
Gross profit
$10.09M
Operating income
-$111.62M
Net income
-$119.48M
Gross margin
64.7%
Net margin
-765.4%
The company's operating margin has shrunk by 145% YoY and by 9% QoQ
The company's net margin has shrunk by 143% YoY
LQDA's operating income has dropped by 109% year-on-year and by 15% since the previous quarter
LQDA's net income has plunged by 107% YoY and by 7% from the previous quarter
Growth
What is Liquidia's growth rate over time
Valuation
What is Liquidia stock price valuation
P/E
N/A
P/B
7.05
P/S
50.92
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
49.36
Liquidia's EPS has shrunk by 87% YoY and by 3.8% QoQ
LQDA's equity has surged by 130% year-on-year and by 76% since the previous quarter
The stock's P/B is 45% below its last 4 quarters average of 12.8
The stock's price to sales (P/S) is 42% more than its 5-year quarterly average of 35.9 but 10% less than its last 4 quarters average of 56.6
LQDA's revenue is down by 15% YoY but it is up by 5% QoQ
Efficiency
How efficient is Liquidia business performance
Liquidia's return on sales has shrunk by 144% YoY
The ROE has plunged by 90% YoY but it has grown by 15% from the previous quarter
The ROA has contracted by 37% YoY but it has grown by 14% from the previous quarter
The ROIC has contracted by 14% YoY but it has grown by 11% from the previous quarter
Dividends
What is LQDA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for LQDA.
Financial health
How did Liquidia financials performed over time
The total assets is 78% more than the total liabilities
The total assets has soared by 127% YoY and by 43% from the previous quarter
The company's total liabilities has surged by 124% YoY and by 24% QoQ
The company's debt is 4.8% higher than its equity
The company's debt has surged by 139% YoY and by 30% QoQ
LQDA's equity has surged by 130% year-on-year and by 76% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.